Life Technologies Found Liable for Infringing Promegaâs DNA Analysis Patents
On February 23, a district court in the Western District of Wisconsin granted a summary judgment motion finding that various Life Technologies products for DNA analysis, including AmpFISTR PCR kits, infringe Promegaâs Patent Numbers 6,221,598; 6,479,235; 7,008,771; and Re37,984. The court awarded $52 million in damages to Promega.
Promega & Max Planck v. Life Technologies, Docket No. 10-cv-281-bbc (W.D.W).
Promega & Max Planck v. Life Technologies, Docket No. 10-cv-281-bbc (W.D.W).
Comments
Post a Comment